跳至主要内容
临床试验/ISRCTN10746820
ISRCTN10746820进行中(未招募)Unknown

A randomised phase I/II study of Intensity Modulated Arc Therapy techniques in abdominal neuroblastoma

niversity of Birmingham0 个研究点目标入组 50 人开始时间: 2017年2月13日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Any patient with high-risk neuroblastoma of the abdominal or pelvic regions who requires radical radiotherapy
  • 2. Fit to receive radical radiotherapy
  • 3. Aged 18 months or over at diagnosis
  • 4. Informed consent from patient, parent or guardian
  • 5. Documented negative pregnancy test for female patients of child bearing potential
  • 6. Patient agrees to use effective contraception during treatment period (patients of child bearing age)

排除标准

  • Pregnant patient.

研究者

相似试验